TatLK15

General Information


DRACP ID  DRACP05499

Peptide Name   TatLK15

Sequence  RKKRRQRRRGGGKLLKLLLKLLLKLLK

Sequence Length  27

UniProt ID  Not available

PubChem CID  Not available

Origin  Chimeric

Type  Native peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C149H285N53O29

Absent amino acids  ACDEFHIMNPSTVWY

Common amino acids  L

Mass  374719

Pl  13.21

Basic residues  13

Acidic residues  0

Hydrophobic residues  10

Net charge  13

Boman Index  -8189

Hydrophobicity  -77.78

Aliphatic Index  144.44

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24218116

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2322

DRACP is developed by Dr.Zheng's team.